Saxenda Weight Loss: How It Works & What to Expect

If you have been researching Saxenda weight loss as a potential option, you are not alone. Saxenda (liraglutide 3mg) is one of the most widely studied prescription weight management injections available, and for eligible patients, it can produce meaningful, clinically significant results. This guide covers how the medication works, what the clinical evidence actually shows, who qualifies, and what to realistically expect during treatment.

Prescription disclaimer: Saxenda is a prescription-only medication. A consultation with a qualified healthcare professional is required before starting treatment.

What Saxenda is and how it fits into weight management

Saxenda contains liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist. GLP-1 is a hormone your gut naturally releases after eating. It signals to your brain that you are full, slows the rate at which your stomach empties, and helps regulate blood sugar. Saxenda mimics and extends this effect, which means you feel fuller sooner and stay full for longer.

It is approved for adults with a BMI of 30 or above, or a BMI of 27 or above, and at least one weight-related health condition such as type 2 diabetes, high blood pressure, or high cholesterol. It is also approved for adolescents aged 12 to 17 who have obesity and weigh at least 60 kg.

Saxenda is not a standalone solution. The clinical trials that established its efficacy were conducted alongside dietary counselling and increased physical activity. Without those lifestyle components, results are consistently lower.

For a broader view of your options, the weight loss treatments hub at Star Pharmacy covers the full range of prescription and non-prescription approaches currently available.

How Saxenda weight loss actually works in the body

The mechanism behind Saxenda weight loss is straightforward once you understand the role GLP-1 plays normally. After a meal, GLP-1 travels from your gut to your brain, specifically the hypothalamus, where it reduces appetite signals. It also tells your pancreas to release insulin in response to blood sugar, and suppresses glucagon, which would otherwise raise blood sugar levels.

Saxenda amplifies this signal and keeps it active for much longer than your body’s natural GLP-1 response, which fades quickly after eating. The practical result is reduced hunger, fewer cravings, and smaller portions feeling satisfying.

Dosing starts low (0.6 mg in week one) and increases by 0.6 mg each week until reaching the 3.0 mg maintenance dose at week five. This gradual escalation exists specifically to help your body adapt and reduce the intensity of early side effects, particularly nausea.

What the clinical evidence shows

The landmark trial enrolled 3,731 participants over 56 weeks. All participants followed a reduced-calorie diet and increased their physical activity. The results, broken down by response tier:

• Around 85% of participants lost some weight
• Roughly 3 in 5 achieved at least 5% body weight loss
• About 1 in 3 achieved 10% or more
• Approximately 6% achieved 20% or more

A 5% to 10% reduction in body weight is not a small thing. Meta-analyses consistently show this level of loss reduces the risk of developing type 2 diabetes, improves blood pressure, and has a positive effect on cholesterol levels.

Three-year follow-up data from the same trial showed that around 56% of those who responded maintained at least 5% weight loss at year one, with that proportion declining over time, particularly after the medication was stopped. Weight regain after discontinuation is common and expected. This is a characteristic of obesity as a chronic condition, not a personal failing.

Saxenda side effects: what to expect

The most common side effects are gastrointestinal: nausea, diarrhoea, constipation, and vomiting. These typically appear during the dose escalation phase and improve as the body adjusts. In clinical trials, nausea was reported in around 39% of Saxenda users, compared to 14% on placebo.

Practical strategies that help:

• Eat smaller, more frequent meals during the first few weeks
• Avoid high-fat or heavily spiced food when nausea is present
• Stay well hydrated, particularly if diarrhoea occurs
• Take your injection at a consistent time each day

Rare but serious side effects include pancreatitis, gallbladder disease, and changes in mood or depression. There is a boxed warning regarding thyroid tumours based on animal studies, though this has not been observed in human clinical data to date. If you notice a lump in your neck, persistent abdominal pain, or significant changes in mood, contact your prescriber promptly.

How Saxenda weight loss compares to other GLP-1 options

Saxenda is a daily injection. Its closest comparators in the GLP-1 class are semaglutide (Wegovy), which is injected weekly, and tirzepatide (Mounjaro), which acts on both GLP-1 and GIP receptors and is also weekly. Head-to-head trial data shows semaglutide produces slightly higher average weight loss (around 15% in the STEP trials), and tirzepatide higher still.

That does not automatically make Saxenda the inferior choice for every patient. Some people tolerate liraglutide better than semaglutide. Access, cost, and prescriber experience also play a role. If you are considering how these options compare in more detail, the article on Mounjaro vs Wegovy at Star Pharmacy is a useful reference point.

Who qualifies and who should not use Saxenda

You may qualify if:

• Your BMI is 30 or above
• Your BMI is 27 to 29.9 and you have at least one weight-related health condition
• You are aged 12 or older and meet the paediatric criteria (obesity, weight at least 60 kg)

Saxenda is not appropriate if you have:

• A personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia type 2 (MEN 2)
• A history of pancreatitis
• Are pregnant or planning to become pregnant in the near term

A proper consultation will also screen for interactions with insulin and sulfonylureas, as combining these with liraglutide increases the risk of low blood sugar.

Conclusion

Saxenda weight loss treatment is well-evidenced, clinically approved, and can produce meaningful results for eligible patients when combined with dietary changes and increased physical activity. Average weight loss in trials sits between 5% and 10% of body weight, with some patients achieving considerably more. Side effects, particularly nausea, are common early on but tend to settle.

It is not the right choice for everyone, and it is not a permanent fix if used in isolation. If you are considering Saxenda as part of a structured weight management plan, speaking with a prescriber is the right first step.

Saxenda is available at Star Pharmacy with an online consultation. Order Saxenda at Star Pharmacy and start your consultation today.

FAQs

How quickly does Saxenda produce weight loss?

Most people notice reduced appetite within the first week or two, but visible weight loss typically takes four to six weeks. The most significant progress usually occurs between months two and six, once the full 3.0 mg dose is reached and the lifestyle changes compound over time.

Will I regain weight if I stop taking Saxenda?

Most people do regain weight after stopping, often within one to two years. This reflects the biology of obesity as a chronic condition. Maintaining the lifestyle habits built during treatment can slow regain, but the medication’s appetite-suppressing effect does not persist after stopping.

Can Saxenda be used alongside other weight-loss medications?

Saxenda should not be combined with other GLP-1 agonists or insulin without close medical supervision. Combination with stimulant appetite suppressants like phentermine is not currently supported by robust trial data and carries additional risks.

Is Saxenda available without a prescription?

No. Saxenda is a prescription-only medication in the UK. A clinical assessment is required to establish eligibility, rule out contraindications, and arrange appropriate monitoring during treatment.